10-Q Filing

Astrana Health, Inc. CIK: 1083446 Q2 2023

Filing Information

Form Type	10-Q
Accession Number	`0001628280-23-028672`
Period End Date	20230630
Filing Date	20230809
Fiscal Year	2023
Fiscal Period	Q2
XBRL Instance	ameh-20230630_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 107 Income Statement 76 Cash Flow Statement 119 Stockholders Equity 49

Balance Sheet 107 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$293.92M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$234.22M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$288.03M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Restricted cash	`RestrictedCash`	$345.00K	USD	Point-in-time
Restricted cash	`RestrictedCash`	-	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Investments in marketable securities	`MarketableSecuritiesCurrent`	$3.79M	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Investments in marketable securities	`MarketableSecuritiesCurrent`	$5.57M	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	46.58M	shares	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	46.55M	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	46.58M	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	46.55M	shares	Point-in-time
Other receivables	`OtherReceivablesNetCurrent`	$1.20M	USD	Point-in-time
Other receivables	`OtherReceivablesNetCurrent`	$1.83M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$15.09M	USD	Point-in-time
Treasury shares (in shares)	`TreasuryStockCommonShares`	10.57M	shares	Point-in-time
Treasury shares (in shares)	`TreasuryStockCommonShares`	10.30M	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$14.80M	USD	Point-in-time
Assets	`Assets`	$966.21M	USD	Point-in-time
Assets	`Assets`	$1.03B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$428.12M	USD	Point-in-time
Liabilities	`Liabilities`	$407.67M	USD	Point-in-time
Liabilities	`Liabilities`	$443.58M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$465.06M	USD	Point-in-time
Land, property, and equipment, net	`PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization`	$108.54M	USD	Point-in-time
Land, property, and equipment, net	`PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization`	$123.86M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$74.42M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$76.86M	USD	Point-in-time
Goodwill	`Goodwill`	$274.03M	USD	Point-in-time
Goodwill	`Goodwill`	$269.05M	USD	Point-in-time
Income taxes receivable, non-current	`IncomeTaxesReceivableNoncurrent`	$15.94M	USD	Point-in-time
Income taxes receivable, non-current	`IncomeTaxesReceivableNoncurrent`	$15.94M	USD	Point-in-time
Investments in other entities equity method	`EquityMethodInvestments`	$45.83M	USD	Point-in-time
Investments in other entities equity method	`EquityMethodInvestments`	$43.11M	USD	Point-in-time
Investments in other entities equity method	`EquityMethodInvestments`	$41.72M	USD	Point-in-time
Investments in other entities equity method	`EquityMethodInvestments`	$40.30M	USD	Point-in-time
Investments in other entities equity method	`EquityMethodInvestments`	$43.82M	USD	Point-in-time
Investments in other entities equity method	`EquityMethodInvestments`	$44.38M	USD	Point-in-time
Investments in privately held entities	`InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue`	$2.90M	USD	Point-in-time
Investments in privately held entities	`InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue`	$896.00K	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$20.44M	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$17.91M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$7.23M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$6.06M	USD	Point-in-time
Total non-current assets	`AssetsNoncurrent`	$538.09M	USD	Point-in-time
Total non-current assets	`AssetsNoncurrent`	$562.11M	USD	Point-in-time
Total assets	`Assets`	$966.21M	USD	Point-in-time
Total assets	`Assets`	$1.03B	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$49.90M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$49.56M	USD	Point-in-time
Fiduciary accounts payable	`FiduciaryAccountsPayableCurrent`	$8.60M	USD	Point-in-time
Fiduciary accounts payable	`FiduciaryAccountsPayableCurrent`	$8.06M	USD	Point-in-time
Medical liabilities	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$100.05M	USD	Point-in-time
Medical liabilities	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$55.78M	USD	Point-in-time
Medical liabilities	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$81.25M	USD	Point-in-time
Medical liabilities	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$112.50M	USD	Point-in-time
Income taxes payable	`AccruedIncomeTaxesCurrent`	$20.35M	USD	Point-in-time
Income taxes payable	`AccruedIncomeTaxesCurrent`	$4.28M	USD	Point-in-time
Dividend payable	`DividendsPayableCurrent`	$638.00K	USD	Point-in-time
Dividend payable	`DividendsPayableCurrent`	$664.00K	USD	Point-in-time
Finance lease liabilities	`FinanceLeaseLiabilityCurrent`	$591.00K	USD	Point-in-time
Finance lease liabilities	`FinanceLeaseLiabilityCurrent`	$594.00K	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$3.57M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$3.03M	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtCurrent`	$619.00K	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtCurrent`	$2.63M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$148.61M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$185.79M	USD	Point-in-time
Deferred tax liability	`DeferredIncomeTaxLiabilitiesNet`	$14.22M	USD	Point-in-time
Deferred tax liability	`DeferredIncomeTaxLiabilitiesNet`	$12.34M	USD	Point-in-time
Finance lease liabilities, net of current portion	`FinanceLeaseLiabilityNoncurrent`	$1.08M	USD	Point-in-time
Finance lease liabilities, net of current portion	`FinanceLeaseLiabilityNoncurrent`	$1.27M	USD	Point-in-time
Operating lease liabilities, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$17.85M	USD	Point-in-time
Operating lease liabilities, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$19.91M	USD	Point-in-time
Long-term debt, net of current portion and deferred financing costs	`LongTermDebtNoncurrent`	$205.14M	USD	Point-in-time
Long-term debt, net of current portion and deferred financing costs	`LongTermDebtNoncurrent`	$203.39M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$20.26M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$21.38M	USD	Point-in-time
Total non-current liabilities	`LiabilitiesNoncurrent`	$259.06M	USD	Point-in-time
Total non-current liabilities	`LiabilitiesNoncurrent`	$257.78M	USD	Point-in-time
Total liabilities	`Liabilities`	$407.67M	USD	Point-in-time
Total liabilities	`Liabilities`	$443.58M	USD	Point-in-time
Commitments and contingencies (Note 12)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 12)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Non-controlling interest in Allied Physicians of California, a Professional Medical Corporation	`TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests`	$13.85M	USD	Point-in-time
Non-controlling interest in Allied Physicians of California, a Professional Medical Corporation	`TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests`	$14.24M	USD	Point-in-time
Common stock, $0.001 par value per share; 100,000,000 shares authorized, 46,553,517 and 46,575,699 shares issued and outstanding, excluding 10,569,340 and 10,299,259 treasury shares, as of June 30, 2023 and December 31, 2022, respectively	`CommonStockValue`	$47.00K	USD	Point-in-time
Common stock, $0.001 par value per share; 100,000,000 shares authorized, 46,553,517 and 46,575,699 shares issued and outstanding, excluding 10,569,340 and 10,299,259 treasury shares, as of June 30, 2023 and December 31, 2022, respectively	`CommonStockValue`	$47.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$360.10M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$357.25M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$208.72M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$182.42M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$542.56M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$566.01M	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$3.74M	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$1.75M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$544.31M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$454.11M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$479.51M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$569.75M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$472.64M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$551.01M	USD	Point-in-time
Total liabilities, mezzanine equity and equity	`LiabilitiesAndStockholdersEquity`	$966.21M	USD	Point-in-time
Total liabilities, mezzanine equity and equity	`LiabilitiesAndStockholdersEquity`	$1.03B	USD	Point-in-time

Income Statement 76 line items

Line Item	Tag	Value	Unit	Period
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$685.45M	USD	2 Qtrs
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$348.21M	USD	1 Quarter
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$532.95M	USD	2 Qtrs
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$269.70M	USD	1 Quarter
Cost of services, excluding depreciation and amortization	`CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization`	$450.80M	USD	2 Qtrs
Cost of services, excluding depreciation and amortization	`CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization`	$582.27M	USD	2 Qtrs
Cost of services, excluding depreciation and amortization	`CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization`	$230.07M	USD	1 Quarter
Cost of services, excluding depreciation and amortization	`CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization`	$292.88M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$31.84M	USD	2 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$45.24M	USD	2 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$24.06M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$19.89M	USD	1 Quarter
Depreciation and amortization	`CostOfGoodsAndServicesSoldDepreciationAndAmortization`	$8.54M	USD	2 Qtrs
Depreciation and amortization	`CostOfGoodsAndServicesSoldDepreciationAndAmortization`	$8.72M	USD	2 Qtrs
Depreciation and amortization	`CostOfGoodsAndServicesSoldDepreciationAndAmortization`	$4.25M	USD	1 Quarter
Depreciation and amortization	`CostOfGoodsAndServicesSoldDepreciationAndAmortization`	$4.35M	USD	1 Quarter
Total expenses	`CostsAndExpenses`	$321.18M	USD	1 Quarter
Total expenses	`CostsAndExpenses`	$491.36M	USD	2 Qtrs
Total expenses	`CostsAndExpenses`	$636.05M	USD	2 Qtrs
Total expenses	`CostsAndExpenses`	$254.31M	USD	1 Quarter
Income from operations	`OperatingIncomeLoss`	$41.59M	USD	2 Qtrs
Income from operations	`OperatingIncomeLoss`	$15.38M	USD	1 Quarter
Income from operations	`OperatingIncomeLoss`	$49.40M	USD	2 Qtrs
Income from operations	`OperatingIncomeLoss`	$27.03M	USD	1 Quarter
Income from equity method investments	`IncomeLossFromEquityMethodInvestments`	$5.21M	USD	2 Qtrs
Income from equity method investments	`IncomeLossFromEquityMethodInvestments`	$1.51M	USD	1 Quarter
Income from equity method investments	`IncomeLossFromEquityMethodInvestments`	$2.94M	USD	2 Qtrs
Income from equity method investments	`IncomeLossFromEquityMethodInvestments`	$2.72M	USD	1 Quarter
Interest expense	`InterestExpense`	$3.63M	USD	1 Quarter
Interest expense	`InterestExpense`	$2.93M	USD	2 Qtrs
Interest expense	`InterestExpense`	$6.90M	USD	2 Qtrs
Interest expense	`InterestExpense`	$1.85M	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$3.33M	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$421.00K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$6.33M	USD	2 Qtrs
Interest income	`InvestmentIncomeInterest`	$467.00K	USD	2 Qtrs
Unrealized gain (loss) on investments	`UnrealizedGainLossOnInvestments`	$-5.53M	USD	2 Qtrs
Unrealized gain (loss) on investments	`UnrealizedGainLossOnInvestments`	$-10.83M	USD	2 Qtrs
Unrealized gain (loss) on investments	`UnrealizedGainLossOnInvestments`	$859.00K	USD	1 Quarter
Unrealized gain (loss) on investments	`UnrealizedGainLossOnInvestments`	$-1.87M	USD	1 Quarter
Other income	`OtherNonoperatingIncomeExpense`	$3.65M	USD	2 Qtrs
Other income	`OtherNonoperatingIncomeExpense`	$2.39M	USD	2 Qtrs
Other income	`OtherNonoperatingIncomeExpense`	$1.19M	USD	1 Quarter
Other income	`OtherNonoperatingIncomeExpense`	$3.03M	USD	1 Quarter
Total other income (expense), net	`NonoperatingIncomeExpense`	$1.50M	USD	2 Qtrs
Total other income (expense), net	`NonoperatingIncomeExpense`	$1.25M	USD	1 Quarter
Total other income (expense), net	`NonoperatingIncomeExpense`	$4.46M	USD	1 Quarter
Total other income (expense), net	`NonoperatingIncomeExpense`	$-6.70M	USD	2 Qtrs
Income before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$31.49M	USD	1 Quarter
Income before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$16.63M	USD	1 Quarter
Income before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$50.90M	USD	2 Qtrs
Income before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$34.90M	USD	2 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	$12.17M	USD	2 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	$5.35M	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$20.93M	USD	2 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	$14.01M	USD	1 Quarter
Net income	`ProfitLoss`	$17.48M	USD	1 Quarter
Net income	`ProfitLoss`	$29.97M	USD	2 Qtrs
Net income	`ProfitLoss`	$11.28M	USD	1 Quarter
Net income	`ProfitLoss`	$22.73M	USD	2 Qtrs
Net income (loss) attributable to non-controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-673.00K	USD	1 Quarter
Net income (loss) attributable to non-controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$4.31M	USD	1 Quarter
Net income (loss) attributable to non-controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$3.67M	USD	2 Qtrs
Net income (loss) attributable to non-controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-2.99M	USD	2 Qtrs
Net income attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$13.17M	USD	1 Quarter
Net income attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$11.95M	USD	1 Quarter
Net income attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$26.30M	USD	2 Qtrs
Net income attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$25.71M	USD	2 Qtrs
Earnings per share basic (in dollars per share)	`EarningsPerShareBasic`	$0.57	USD	2 Qtrs
Earnings per share basic (in dollars per share)	`EarningsPerShareBasic`	$0.28	USD	1 Quarter
Earnings per share basic (in dollars per share)	`EarningsPerShareBasic`	$0.57	USD	2 Qtrs
Earnings per share basic (in dollars per share)	`EarningsPerShareBasic`	$0.27	USD	1 Quarter
Earnings per share diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.56	USD	2 Qtrs
Earnings per share diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.56	USD	2 Qtrs
Earnings per share diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.26	USD	1 Quarter
Earnings per share diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.28	USD	1 Quarter

Cash Flow Statement 119 line items

Line Item	Tag	Value	Unit	Period
Net income	`ProfitLoss`	$17.48M	USD	1 Quarter
Net income	`ProfitLoss`	$29.97M	USD	2 Qtrs
Net income	`ProfitLoss`	$11.28M	USD	1 Quarter
Net income	`ProfitLoss`	$22.73M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$8.54M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$8.72M	USD	2 Qtrs
Amortization of debt issuance cost	`AmortizationOfFinancingCosts`	$474.00K	USD	2 Qtrs
Amortization of debt issuance cost	`AmortizationOfFinancingCosts`	$474.00K	USD	2 Qtrs
Share-based compensation	`ShareBasedCompensation`	$7.66M	USD	2 Qtrs
Share-based compensation	`ShareBasedCompensation`	$6.97M	USD	2 Qtrs
Gain on sale of equity securities	`EquitySecuritiesFvNiRealizedGainLoss`	$2.27M	USD	1 Quarter
Gain on sale of equity securities	`EquitySecuritiesFvNiRealizedGainLoss`	-	USD	2 Qtrs
Gain on sale of equity securities	`EquitySecuritiesFvNiRealizedGainLoss`	-	USD	1 Quarter
Gain on sale of equity securities	`EquitySecuritiesFvNiRealizedGainLoss`	$2.27M	USD	2 Qtrs
Unrealized loss on investments	`UnrealizedGainLossFromInvestmentInEquitySecurities`	$-5.49M	USD	2 Qtrs
Unrealized loss on investments	`UnrealizedGainLossFromInvestmentInEquitySecurities`	$-13.66M	USD	2 Qtrs
Income from equity method investments	`IncomeLossFromEquityMethodInvestments`	$5.21M	USD	2 Qtrs
Income from equity method investments	`IncomeLossFromEquityMethodInvestments`	$1.51M	USD	1 Quarter
Income from equity method investments	`IncomeLossFromEquityMethodInvestments`	$2.94M	USD	2 Qtrs
Income from equity method investments	`IncomeLossFromEquityMethodInvestments`	$2.72M	USD	1 Quarter
Unrealized loss (gain) on interest rate swaps	`UnrealizedGainLossOnDerivatives`	$-49.00K	USD	2 Qtrs
Unrealized loss (gain) on interest rate swaps	`UnrealizedGainLossOnDerivatives`	$2.83M	USD	2 Qtrs
Deferred tax	`DeferredIncomeTaxesAndTaxCredits`	$-3.75M	USD	2 Qtrs
Deferred tax	`DeferredIncomeTaxesAndTaxCredits`	$3.36M	USD	2 Qtrs
Receivables, net	`IncreaseDecreaseInAccountsReceivable`	$17.30M	USD	2 Qtrs
Receivables, net	`IncreaseDecreaseInAccountsReceivable`	$56.20M	USD	2 Qtrs
Receivables, net related parties	`IncreaseDecreaseInDueFromRelatedParties`	$17.67M	USD	2 Qtrs
Receivables, net related parties	`IncreaseDecreaseInDueFromRelatedParties`	$12.15M	USD	2 Qtrs
Other receivables	`IncreaseDecreaseInOtherReceivables`	$3.58M	USD	2 Qtrs
Other receivables	`IncreaseDecreaseInOtherReceivables`	$-1.23M	USD	2 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets`	$-4.11M	USD	2 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets`	$2.28M	USD	2 Qtrs
Right-of-use assets	`IncreaseDecreaseInOperatingLeaseAssets`	$3.24M	USD	2 Qtrs
Right-of-use assets	`IncreaseDecreaseInOperatingLeaseAssets`	$2.29M	USD	2 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-1.79M	USD	2 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$21.00K	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$14.18M	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-2.86M	USD	2 Qtrs
Fiduciary accounts payable	`IncreaseDecreaseInOtherAccountsPayable`	$-4.46M	USD	2 Qtrs
Fiduciary accounts payable	`IncreaseDecreaseInOtherAccountsPayable`	$538.00K	USD	2 Qtrs
Medical liabilities	`IncreaseDecreaseInMedicalLiabilities`	$55.11M	USD	2 Qtrs
Medical liabilities	`IncreaseDecreaseInMedicalLiabilities`	$13.34M	USD	2 Qtrs
Income taxes payable/receivable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$-14.01M	USD	2 Qtrs
Income taxes payable/receivable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$15.40M	USD	2 Qtrs
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-3.31M	USD	2 Qtrs
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-2.25M	USD	2 Qtrs
Other long-term liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$370.00K	USD	2 Qtrs
Other long-term liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	-	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$33.06M	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$33.52M	USD	2 Qtrs
Payments for business and asset acquisitions, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$-350.00K	USD	2 Qtrs
Payments for business and asset acquisitions, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$858.00K	USD	2 Qtrs
Proceeds from repayment of loans receivable related parties	`ProceedsFromCollectionOfLongtermLoansToRelatedParties`	$2.14M	USD	2 Qtrs
Proceeds from repayment of loans receivable related parties	`ProceedsFromCollectionOfLongtermLoansToRelatedParties`	$4.03M	USD	2 Qtrs
Purchase of marketable securities	`PaymentsToAcquireMarketableSecurities`	$2.02M	USD	2 Qtrs
Purchase of marketable securities	`PaymentsToAcquireMarketableSecurities`	$1.75M	USD	2 Qtrs
Purchase of investments - privately held	`PaymentsToAcquireTradingSecuritiesHeldforinvestment`	$2.00M	USD	2 Qtrs
Purchase of investments - privately held	`PaymentsToAcquireTradingSecuritiesHeldforinvestment`	-	USD	2 Qtrs
Purchase of investments - equity method	`PaymentsToAcquireEquityMethodInvestments`	$325.00K	USD	2 Qtrs
Purchase of investments - equity method	`PaymentsToAcquireEquityMethodInvestments`	-	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$18.84M	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$17.37M	USD	2 Qtrs
Proceeds from sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$6.48M	USD	2 Qtrs
Proceeds from sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	-	USD	2 Qtrs
Distribution from investment - equity method	`ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital`	-	USD	2 Qtrs
Distribution from investment - equity method	`ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital`	$400.00K	USD	2 Qtrs
Contribution to investment - equity method	`PaymentsToEquityMethodInvestments`	$1.69M	USD	2 Qtrs
Contribution to investment - equity method	`PaymentsToEquityMethodInvestments`	-	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-19.22M	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-12.23M	USD	2 Qtrs
Dividends paid	`PaymentsOfDividends`	$842.00K	USD	2 Qtrs
Dividends paid	`PaymentsOfDividends`	$12.56M	USD	2 Qtrs
Repayment of long-term debt	`RepaymentsOfLongTermDebt`	$312.00K	USD	2 Qtrs
Repayment of long-term debt	`RepaymentsOfLongTermDebt`	$200.00K	USD	2 Qtrs
Payment of finance lease obligations	`RepaymentsOfDebtAndCapitalLeaseObligations`	$283.00K	USD	2 Qtrs
Payment of finance lease obligations	`RepaymentsOfDebtAndCapitalLeaseObligations`	$303.00K	USD	2 Qtrs
Proceeds from the exercise of stock options and warrants	`ProceedsFromWarrantExercises`	$1.74M	USD	2 Qtrs
Proceeds from the exercise of stock options and warrants	`ProceedsFromWarrantExercises`	$1.25M	USD	2 Qtrs
Repurchase of shares	`PaymentsForRepurchaseOfCommonStock`	$9.48M	USD	2 Qtrs
Repurchase of shares	`PaymentsForRepurchaseOfCommonStock`	$9.54M	USD	2 Qtrs
Proceeds from sale of non-controlling interest	`ProceedsFromPaymentsToMinorityShareholders`	-	USD	2 Qtrs
Proceeds from sale of non-controlling interest	`ProceedsFromPaymentsToMinorityShareholders`	$38.00K	USD	2 Qtrs
Purchase of non-controlling interest	`PurchaseOfNonControllingInterest`	$50.00K	USD	2 Qtrs
Purchase of non-controlling interest	`PurchaseOfNonControllingInterest`	$199.00K	USD	2 Qtrs
Borrowings on loans	`ProceedsFromIssuanceOfOtherLongTermDebt`	$1.73M	USD	2 Qtrs
Borrowings on loans	`ProceedsFromIssuanceOfOtherLongTermDebt`	$1.24M	USD	2 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-19.70M	USD	2 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-8.06M	USD	2 Qtrs
Net increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$6.24M	USD	2 Qtrs
Net increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$1.13M	USD	2 Qtrs
Cash and cash equivalents beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$233.10M	USD	Point-in-time
Cash and cash equivalents beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$234.22M	USD	Point-in-time
Cash and cash equivalents beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$288.03M	USD	Point-in-time
Cash and cash equivalents beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$294.27M	USD	Point-in-time
Cash and cash equivalents end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$233.10M	USD	Point-in-time
Cash and cash equivalents end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$234.22M	USD	Point-in-time
Cash and cash equivalents end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$288.03M	USD	Point-in-time
Cash and cash equivalents end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$294.27M	USD	Point-in-time
Cash paid for income taxes	`IncomeTaxesPaid`	$7.88M	USD	2 Qtrs
Cash paid for income taxes	`IncomeTaxesPaid`	$22.31M	USD	2 Qtrs
Cash paid for interest	`InterestPaidNet`	$2.23M	USD	2 Qtrs
Cash paid for interest	`InterestPaidNet`	$6.26M	USD	2 Qtrs
Right-of-use assets obtained in exchange for operating lease liabilities	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	$701.00K	USD	2 Qtrs
Right-of-use assets obtained in exchange for operating lease liabilities	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	-	USD	2 Qtrs
Fixed asset obtained in exchange for finance lease liabilities	`RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability`	-	USD	2 Qtrs
Fixed asset obtained in exchange for finance lease liabilities	`RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability`	$398.00K	USD	2 Qtrs
Common stock issued in business combination	`StockIssued1`	$1.00M	USD	2 Qtrs
Common stock issued in business combination	`StockIssued1`	-	USD	2 Qtrs
Mortgage loan	`MortgageLoanRelatedToPropertySales1`	-	USD	2 Qtrs
Mortgage loan	`MortgageLoanRelatedToPropertySales1`	$16.27M	USD	2 Qtrs
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$293.92M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$234.22M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$288.03M	USD	Point-in-time
Restricted cash current	`RestrictedCashEquivalentsCurrent`	-	USD	Point-in-time
Restricted cash current	`RestrictedCashEquivalentsCurrent`	$345.00K	USD	Point-in-time
Total cash, cash equivalents, and restricted cash shown in the statement of cash flows	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$233.10M	USD	Point-in-time
Total cash, cash equivalents, and restricted cash shown in the statement of cash flows	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$234.22M	USD	Point-in-time
Total cash, cash equivalents, and restricted cash shown in the statement of cash flows	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$288.03M	USD	Point-in-time
Total cash, cash equivalents, and restricted cash shown in the statement of cash flows	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$294.27M	USD	Point-in-time

Stockholders Equity 49 line items

Line Item	Tag	Value	Unit	Period
Temporary equity, carrying amount, beginning balance	`TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests`	$13.85M	USD	Point-in-time
Temporary equity, carrying amount, beginning balance	`TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests`	$14.24M	USD	Point-in-time
Tax impact from dividends	`TemporaryEquityDividendsImpact`	$-3.08M	USD	1 Quarter
Tax impact from dividends	`TemporaryEquityDividendsImpact`	$3.08M	USD	2 Qtrs
Tax impact from dividends	`TemporaryEquityDividendsImpact`	-	USD	2 Qtrs
Temporary equity, carrying amount, ending balance	`TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests`	$13.85M	USD	Point-in-time
Temporary equity, carrying amount, ending balance	`TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests`	$14.24M	USD	Point-in-time
Equity, beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$544.31M	USD	Point-in-time
Equity, beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$454.11M	USD	Point-in-time
Equity, beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$479.51M	USD	Point-in-time
Equity, beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$569.75M	USD	Point-in-time
Equity, beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$472.64M	USD	Point-in-time
Equity, beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$551.01M	USD	Point-in-time
Net (loss) income (restated)	`NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity`	$14.22M	USD	1 Quarter
Net (loss) income (restated)	`NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity`	$14.70M	USD	1 Quarter
Net (loss) income (restated)	`NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity`	$14.24M	USD	1 Quarter
Net (loss) income (restated)	`NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity`	$13.30M	USD	1 Quarter
Purchase of non-controlling interest	`MinorityInterestDecreaseFromRedemptions`	$50.00K	USD	1 Quarter
Purchase of non-controlling interest	`MinorityInterestDecreaseFromRedemptions`	$200.00K	USD	1 Quarter
Sale of non-controlling interest	`NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest`	$36.00K	USD	1 Quarter
Sale of non-controlling interest	`NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest`	$106.00K	USD	1 Quarter
Shares issued for vesting of restricted stock awards	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	$-464.00K	USD	1 Quarter
Shares issued for vesting of restricted stock awards	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	$-109.00K	USD	1 Quarter
Shares issued for vesting of restricted stock awards	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	$-253.00K	USD	1 Quarter
Shares issued for exercise of options and warrants	`StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants`	$1.57M	USD	1 Quarter
Shares issued for exercise of options and warrants	`StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants`	$165.00K	USD	1 Quarter
Shares issued for exercise of options and warrants	`StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants`	$1.25M	USD	1 Quarter
Purchase of treasury shares (in shares)	`TreasuryStockSharesAcquired`	270,081.00	shares	2 Qtrs
Purchase of treasury shares	`TreasuryStockValueAcquiredParValueMethod`	$9.54M	USD	1 Quarter
Purchase of treasury shares	`TreasuryStockValueAcquiredParValueMethod`	$9.25M	USD	1 Quarter
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$3.92M	USD	1 Quarter
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$3.44M	USD	1 Quarter
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$4.21M	USD	1 Quarter
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$3.06M	USD	1 Quarter
Issuance of shares for business acquisition	`StockIssuedDuringPeriodValueAcquisitions`	$800.00K	USD	1 Quarter
Issuance of shares for business acquisition	`StockIssuedDuringPeriodValueAcquisitions`	$1.00M	USD	1 Quarter
Cancellation of restricted stock awards	`StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures`	$457.00K	USD	1 Quarter
Investment in non-controlling interest	`NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance`	$371.00K	USD	1 Quarter
Dividends	`NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares`	$-120.00K	USD	1 Quarter
Dividends	`NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares`	$-1.37M	USD	1 Quarter
Dividends	`NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares`	$-96.00K	USD	1 Quarter
Dividends	`NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares`	$-1.18M	USD	1 Quarter
Transfer of common control entities (restated)	`TransferOfCommonControlEntities`	$-2.45M	USD	1 Quarter
Equity, ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$544.31M	USD	Point-in-time
Equity, ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$454.11M	USD	Point-in-time
Equity, ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$479.51M	USD	Point-in-time
Equity, ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$569.75M	USD	Point-in-time
Equity, ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$472.64M	USD	Point-in-time
Equity, ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$551.01M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.